Patent ID: 11919934
Assignee: SYNTHORX, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC C

Claim 4:
5. The modified IL-15 polypeptide of claim 4, wherein the conjugating moiety comprises a water-soluble polymer, and wherein the water-soluble polymer comprises polyethylene glycol (PEG), poly(propylene glycol) (PPG), copolymers of ethylene glycol and propylene glycol, poly(oxyethylated polyol), poly(olefinic alcohol), poly(vinylpyrrolidone), poly(hydroxyalkylmethacrylamide), poly(hydroxyalkylmethacrylate), poly(saccharides), poly(a-hydroxy acid), poly(vinyl alcohol), polyphosphazene, polyoxazolines (POZ), poly(N-acryloylmorpholine), or a combination thereof.